EVE Historical Income Statement

EVE Stock

0 0.00 0.00%

Historical analysis of EVE Health income statement accounts such as Selling General Administrative of 625.9 K or Other Operating Expenses of 2.8 M can show how well EVE Health Group performed in making a profits. Evaluating EVE Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of EVE Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining EVE Health Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether EVE Health Group is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About EVE Income Statement Analysis

EVE Health Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to EVE Health shareholders. The income statement also shows EVE investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

EVE Health Income Statement Chart

At this time, EVE Health's Interest Expense is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 2.4 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 2.8 M in 2024.

Selling General Administrative Other Operating Expenses Total Operating Expenses Selling And Marketing Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of EVE Health Group. It is also known as EVE Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from EVE Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into EVE Health Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

EVE Health income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Total Revenue	Gross Profit	Discontinued Operations	Selling And Marketing Expenses	Net Income From Continuing Ops	Cost Of Revenue	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		-0.1	-0.07	0.13	-0.21	-0.12	-0.03	0.03	0.1	0.11	0.11	-0.13	-0.04	-0.16	0.34	0.23	-0.23	0.0	0.15	0.27	-0.02	0.18
Interest Expense	-0.1		-0.17	0.64	-0.46	-0.22	-0.23	0.18	0.2	0.23	0.16	-0.17	0.68	0.07	0.42	0.2	-0.5	0.6	0.37	0.53	-0.02	-0.09
Selling General Administrative	-0.07	-0.17		-0.2	0.07	0.04	0.04	0.0	-0.02	-0.07	0.01	-0.04	-0.2	0.56	-0.04	-0.05	0.31	-0.34	-0.13	0.04	0.24	-0.51
Other Operating Expenses	0.13	0.64	-0.2		-0.93	-0.35	-0.34	0.25	0.13	0.26	0.07	-0.2	0.95	-0.45	0.61	0.68	-0.87	0.96	0.19	0.65	-0.38	0.46
Operating Income	-0.21	-0.46	0.07	-0.93		0.35	0.33	-0.21	-0.07	-0.21	-0.02	0.2	-0.79	0.57	-0.59	-0.7	0.88	-0.87	-0.15	-0.58	0.5	-0.59
Ebit	-0.12	-0.22	0.04	-0.35	0.35		1.0	-0.55	-0.68	-0.91	-0.67	0.92	-0.32	0.18	-0.35	-0.35	0.38	-0.34	-0.11	-0.34	0.2	-0.18
Ebitda	-0.03	-0.23	0.04	-0.34	0.33	1.0		-0.55	-0.68	-0.91	-0.66	0.91	-0.33	0.17	-0.32	-0.33	0.37	-0.34	-0.1	-0.32	0.2	-0.16
Total Operating Expenses	0.03	0.18	0.0	0.25	-0.21	-0.55	-0.55		-0.16	0.23	-0.17	-0.23	0.23	-0.08	0.0	0.16	-0.2	0.24	-0.03	0.03	-0.12	0.1
Income Before Tax	0.1	0.2	-0.02	0.13	-0.07	-0.68	-0.68	-0.16		0.91	0.99	-0.89	0.19	0.11	0.41	0.19	-0.15	0.14	0.2	0.44	0.09	-0.11
Total Other Income Expense Net	0.11	0.23	-0.07	0.26	-0.21	-0.91	-0.91	0.23	0.91		0.9	-0.97	0.3	-0.04	0.44	0.31	-0.31	0.29	0.19	0.46	-0.05	0.05
Net Income	0.11	0.16	0.01	0.07	-0.02	-0.67	-0.66	-0.17	0.99	0.9		-0.89	0.12	0.14	0.38	0.12	-0.1	0.07	0.23	0.39	0.11	-0.12
Income Tax Expense	-0.13	-0.17	-0.04	-0.2	0.2	0.92	0.91	-0.23	-0.89	-0.97	-0.89		-0.19	0.01	-0.35	-0.19	0.23	-0.18	-0.21	-0.34	0.04	-0.03
Total Revenue	-0.04	0.68	-0.2	0.95	-0.79	-0.32	-0.33	0.23	0.19	0.3	0.12	-0.19		-0.27	0.55	0.64	-0.75	0.96	0.16	0.66	-0.23	0.28
Gross Profit	-0.16	0.07	0.56	-0.45	0.57	0.18	0.17	-0.08	0.11	-0.04	0.14	0.01	-0.27		-0.24	-0.34	0.59	-0.49	-0.1	-0.03	0.53	-0.97
Discontinued Operations	0.34	0.42	-0.04	0.61	-0.59	-0.35	-0.32	0.0	0.41	0.44	0.38	-0.35	0.55	-0.24		0.6	-0.72	0.56	0.52	0.95	-0.22	0.26
Selling And Marketing Expenses	0.23	0.2	-0.05	0.68	-0.7	-0.35	-0.33	0.16	0.19	0.31	0.12	-0.19	0.64	-0.34	0.6		-0.81	0.68	-0.24	0.67	-0.64	0.3
Net Income From Continuing Ops	-0.23	-0.5	0.31	-0.87	0.88	0.38	0.37	-0.2	-0.15	-0.31	-0.1	0.23	-0.75	0.59	-0.72	-0.81		-0.85	-0.2	-0.68	0.69	-0.58
Cost Of Revenue	0.0	0.6	-0.34	0.96	-0.87	-0.34	-0.34	0.24	0.14	0.29	0.07	-0.18	0.96	-0.49	0.56	0.68	-0.85		0.15	0.62	-0.37	0.5
Interest Income	0.15	0.37	-0.13	0.19	-0.15	-0.11	-0.1	-0.03	0.2	0.19	0.23	-0.21	0.16	-0.1	0.52	-0.24	-0.2	0.15		0.4	0.16	0.14
Extraordinary Items	0.27	0.53	0.04	0.65	-0.58	-0.34	-0.32	0.03	0.44	0.46	0.39	-0.34	0.66	-0.03	0.95	0.67	-0.68	0.62	0.4		-0.16	0.03
Net Interest Income	-0.02	-0.02	0.24	-0.38	0.5	0.2	0.2	-0.12	0.09	-0.05	0.11	0.04	-0.23	0.53	-0.22	-0.64	0.69	-0.37	0.16	-0.16		-0.47
Reconciled Depreciation	0.18	-0.09	-0.51	0.46	-0.59	-0.18	-0.16	0.1	-0.11	0.05	-0.12	-0.03	0.28	-0.97	0.26	0.3	-0.58	0.5	0.14	0.03	-0.47

Click cells to compare fundamentals

EVE Health Account Relationship Matchups

EVE Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	277.8K	324.5K	226.3K	166.9K	7.0K	6.7K
Interest Expense	7.3K	48.3K	22.0K	34.9K	40.2K	42.2K
Selling General Administrative	281.4K	327.2K	163.1K	135.5K	992.8K	625.9K
Other Operating Expenses	5.1M	6.6M	5.9M	4.6M	3.7M	2.8M
Operating Income	(2.7M)	(3.8M)	(3.9M)	(2.3M)	(1.5M)	(1.6M)
Ebit	(2.7M)	(3.8M)	(4.8M)	(2.3M)	(1.5M)	(1.6M)
Ebitda	(2.5M)	(3.5M)	(4.5M)	(2.2M)	(1.5M)	(1.6M)
Total Operating Expenses	2.3M	3.1M	2.9M	1.9M	2.4M	2.4M
Income Before Tax	(2.3M)	(3.2M)	(4.8M)	(2.1M)	(1.5M)	(1.6M)
Total Other Income Expense Net	396.4K	629.2K	(457.4K)	249.1K	(5.2K)	(5.4K)
Net Income	(2.4M)	(3.6M)	(5.4M)	(4.0M)	(1.9M)	(2.0M)
Income Tax Expense	(604.0K)	468.4K	594.6K	1.9M	352.3K	334.7K
Total Revenue	2.3M	2.8M	2.0M	2.3M	2.1M	1.4M
Net Income Applicable To Common Shares	(2.4M)	(3.6M)	(5.4M)	(1.6M)	(1.5M)	(1.4M)
Gross Profit	(451.9K)	(713.5K)	(1.0M)	(336.9K)	877.0K	920.8K
Selling And Marketing Expenses	670.1K	1.2M	2.0M	1.3M	1.1M	911.4K
Net Income From Continuing Ops	(2.4M)	(3.6M)	(5.4M)	(2.3M)	(1.5M)	(1.6M)
Cost Of Revenue	2.8M	3.5M	3.0M	2.7M	1.3M	1.5M
Interest Income	658.8K	26.3K	7.2K	24.8K	22.4K	21.2K
Net Interest Income	(7.3K)	(22.0K)	(4.0M)	118.0	(34.9K)	(36.7K)
Reconciled Depreciation	277.8K	324.5K	325.7K	166.9K	7.0K	6.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for EVE Stock Analysis

When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EVE Historical Income Statement

About EVE Income Statement Analysis

EVE Health Income Statement Chart

Other Operating Expenses

Total Operating Expenses

EVE Health income statement Correlations

EVE Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EVE Health income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for EVE Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 1.0	Ebit
Net Income	+ 0.99	Income Before Tax
Cost Of Revenue	+ 0.96	Other Operating Expenses
Cost Of Revenue	+ 0.96	Total Revenue
Total Revenue	+ 0.95	Other Operating Expenses
Extraordinary Items	+ 0.95	Discontinued Operations

Reconciled Depreciation	- 0.97	Gross Profit
Income Tax Expense	- 0.97	Total Other Income Expense Net
Operating Income	- 0.93	Other Operating Expenses
Total Other Income Expense Net	- 0.91	Ebitda
Total Other Income Expense Net	- 0.91	Ebit
Income Tax Expense	- 0.89	Net Income